TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+10.56%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.98B
AUM Growth
+$1.98B
(+9.4%)
Cap. Flow
+$95.2M
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
220
New
18
Increased
33
Reduced
53
Closed
20
Top Buys
| 1 |
Vera Therapeutics
VERA
|
$28.3M |
| 2 |
Merus
MRUS
|
$26.3M |
| 3 |
Mettler-Toledo International
MTD
|
$22.9M |
| 4 |
Boeing
BA
|
$20.9M |
| 5 |
Spyre Therapeutics
SYRE
|
$17.2M |
Top Sells
| 1 |
Dynavax Technologies
DVAX
|
$37.7M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$29M |
| 3 |
SLRN
ACELYRIN
SLRN
|
$24.3M |
| 4 |
Bolt Biotherapeutics
BOLT
|
$21M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.1M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Technology | 1.37% |
| 3 | Industrials | 1.32% |
| 4 | Communication Services | 1.26% |
| 5 | Consumer Discretionary | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Galapagos
GLPG
$2.07B
| $112M | 5.65% | 3,990,111 +28,314 | +0.7% | +$793K |
|
2
Tarsus Pharmaceuticals
TARS
$2.47B
| $99.4M | 5.03% | 2,454,797 | – | – |
|
3
Aurinia Pharmaceuticals
AUPH
$1.58B
| $84.9M | 4.29% | 10,029,500 | – | – |
|
4
Immunocore
IMCR
$1.62B
| $66.1M | 3.34% | 2,105,608 +189,900 | +10% | +$5.96M |
|
5
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $64.4M | 3.26% | 2,328,609 +210,030 | +10% | +$5.81M |
|
6
Mirum Pharmaceuticals
MIRM
$3.71B
| $62.9M | 3.18% | 1,236,027 -1,080 | -0.1% | -$55K |
|
7
KalVista Pharmaceuticals
KALV
$678M
| $55.9M | 2.82% | 4,941,798 | – | – |
|
8
PTC Therapeutics
PTCT
$3.92B
| $53.7M | 2.72% | 1,100,000 +100,000 | +10% | +$4.88M |
|
|
9
Spyre Therapeutics
SYRE
$996M
| $47.9M | 2.42% | 3,200,000 +1,150,000 | +56% | +$17.2M |
|
10
Evolus
EOLS
$494M
| $46M | 2.33% | 4,997,399 | – | – |
|
11
Viridian Therapeutics
VRDN
$1.5B
| $39.7M | 2.01% | 2,842,925 +50,000 | +2% | +$699K |
|
12
iTeos Therapeutics
ITOS
| $38.2M | 1.93% | 3,826,692 +1,137,492 | +42% | +$11.3M |
|
13
Compass Therapeutics
CMPX
$483M
| $35.1M | 1.77% | 13,496,208 +2,443,576 | +22% | +$6.35M |
|
14
Acadia Pharmaceuticals
ACAD
$4.38B
| $32.4M | 1.64% | 1,500,000 | – | – |
|
|
15
Vera Therapeutics
VERA
$1.38B
| $31.8M | 1.61% | 1,350,000 +1,200,000 | +800% | +$28.3M |
|
|
16
Merus
MRUS
$4.98B
| $31.6M | 1.6% | 600,000 +500,000 | +500% | +$26.3M |
|
17
Replimune Group
REPL
$422M
| $29.7M | 1.5% | 3,200,000 +300,000 | +10% | +$2.79M |
|
18
AnaptysBio
ANAB
$569M
| $29.5M | 1.49% | 1,330,879 -214,274 | -14% | -$4.76M |
|
19
Legend Biotech
LEGN
$6.41B
| $29.5M | 1.49% | 830,000 | – | – |
|
20
BioNTech
BNTX
$24B
| $28.7M | 1.45% | 270,000 | – | – |
|
21
Relay Therapeutics
RLAY
$619M
| $27.9M | 1.41% | 8,068,058 | – | – |
|
|
LENZ
22
LENZ Therapeutics
LENZ
$1.1B
| $26.3M | 1.33% | 897,616 +130,676 | +17% | +$3.83M |
|
23
CytomX Therapeutics
CTMX
$336M
| $25.1M | 1.27% | 11,065,662 +4,347,837 | +65% | +$9.87M |
|
|
24
Mettler-Toledo International
MTD
$26.8B
| $22.9M | 1.16% | +19,500 | New | +$22.9M |
|
|
25
Boeing
BA
$177B
| $22.1M | 1.12% | 105,662 +99,594 | +1,641% | +$20.9M |
|